Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Abingworthabingworth.com · Low evidenceAbingworth is a life science investment firm that has provided capital and strategic support to over a hundred biotech and biopharmaceutical companies since 1987. The firm focuses on early-stage investing, including innovative approaches such as VIPEs (Venture Investments in Public Equities) and Clinical Co-Development.
Parse Score